BAY Area Dialysis Corpus Christi in Corpus Christi, Texas - Dialysis Center

BAY Area Dialysis Corpus Christi is a medicare approved dialysis facility center in Corpus Christi, Texas and it has 21 dialysis stations. It is located in Nueces county at 1647 South Alameda, Corpus Christi, TX, 78404. You can reach out to the office of BAY Area Dialysis Corpus Christi at (361) 888-7547. This dialysis clinic is managed and/or owned by Fresenius Medical Care. BAY Area Dialysis Corpus Christi has the following ownership type - Profit. It was first certified by medicare in March, 1990. The medicare id for this facility is 452619 and it accepts patients under medicare ESRD program.

Dialysis Center Profile

NameBAY Area Dialysis Corpus Christi
Location1647 South Alameda, Corpus Christi, Texas
No. of Dialysis Stations 21
Medicare ID452619
Managed ByFresenius Medical Care
Ownership TypeProfit
Late Shifts Yes

Contact Information


1647 South Alameda, Corpus Christi, Texas, 78404
(361) 888-7547
Not Available

News Archive

Federal nutrition program improves health of pregnant women and children

A major 2009 revision to a federal nutrition program for low-income pregnant women and children improved recipients' health on several key measures, researchers at UC San Francisco have found.

Succimer therapy improves balance and movement in lead-exposed children

University of Cincinnati (UC) environmental health researchers say a therapy commonly used to remove dangerously high levels of lead from the body may also improve muscle functions associated with postural balance and movement in lead-exposed children.

5 ways White House can use its muscle to undercut Obamacare

President Donald Trump has vowed to "let Obamacare fail," after legislative efforts to undo the Affordable Care Act have stalled.

New drug treats inflammation related to inherited heart disease in young athletes

When young athletes experiences sudden cardiac death as they run down the playing field, it's usually due to arrhythmogenic cardiomyopathy, an inherited heart disease.

CytRx provides overview of clinical development programs, reports 2014 Q3 financial results

CytRx Corporation (CYTR), a biopharmaceutical research and development company specializing in oncology, today reported financial results for the three months ended September 30, 2014, and also provided an overview of recent accomplishments by and upcoming milestones for its clinical development programs.

Read more Medical News

› Verified 3 days ago


Map and Direction



NPI Associated with this Dialysis Facility:

Dialysis Facilities may have multiple NPI numbers. We have found possible NPI number/s associated with BAY Area Dialysis Corpus Christi from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number1609966100
Organization NameBay Area Dialysis-corpus Christi
Doing Business AsDialysis Management Corporation
Address1647 S Alameda St Corpus Christi, Texas, 78404
Phone Number(361) 888-7547

News Archive

Federal nutrition program improves health of pregnant women and children

A major 2009 revision to a federal nutrition program for low-income pregnant women and children improved recipients' health on several key measures, researchers at UC San Francisco have found.

Succimer therapy improves balance and movement in lead-exposed children

University of Cincinnati (UC) environmental health researchers say a therapy commonly used to remove dangerously high levels of lead from the body may also improve muscle functions associated with postural balance and movement in lead-exposed children.

5 ways White House can use its muscle to undercut Obamacare

President Donald Trump has vowed to "let Obamacare fail," after legislative efforts to undo the Affordable Care Act have stalled.

New drug treats inflammation related to inherited heart disease in young athletes

When young athletes experiences sudden cardiac death as they run down the playing field, it's usually due to arrhythmogenic cardiomyopathy, an inherited heart disease.

CytRx provides overview of clinical development programs, reports 2014 Q3 financial results

CytRx Corporation (CYTR), a biopharmaceutical research and development company specializing in oncology, today reported financial results for the three months ended September 30, 2014, and also provided an overview of recent accomplishments by and upcoming milestones for its clinical development programs.

Read more Medical News

› Verified 3 days ago


Patient Distribution

Anemia Management

Dialysis patients with Hemoglobin data54

News Archive

Federal nutrition program improves health of pregnant women and children

A major 2009 revision to a federal nutrition program for low-income pregnant women and children improved recipients' health on several key measures, researchers at UC San Francisco have found.

Succimer therapy improves balance and movement in lead-exposed children

University of Cincinnati (UC) environmental health researchers say a therapy commonly used to remove dangerously high levels of lead from the body may also improve muscle functions associated with postural balance and movement in lead-exposed children.

5 ways White House can use its muscle to undercut Obamacare

President Donald Trump has vowed to "let Obamacare fail," after legislative efforts to undo the Affordable Care Act have stalled.

New drug treats inflammation related to inherited heart disease in young athletes

When young athletes experiences sudden cardiac death as they run down the playing field, it's usually due to arrhythmogenic cardiomyopathy, an inherited heart disease.

CytRx provides overview of clinical development programs, reports 2014 Q3 financial results

CytRx Corporation (CYTR), a biopharmaceutical research and development company specializing in oncology, today reported financial results for the three months ended September 30, 2014, and also provided an overview of recent accomplishments by and upcoming milestones for its clinical development programs.

Read more Medical News

› Verified 3 days ago

Dialysis Adequacy

Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.

  • Hemodialysis
    Adult patients getting regular hemodialysis at the center127
    Adult patient months included in Kt/V greater than or equal to 1.21232
    Percentage of adult patients getting regular hemodialysis at the center
    Percentage of pediatric patients getting regular hemodialysis at the center

    News Archive

    Federal nutrition program improves health of pregnant women and children

    A major 2009 revision to a federal nutrition program for low-income pregnant women and children improved recipients' health on several key measures, researchers at UC San Francisco have found.

    Succimer therapy improves balance and movement in lead-exposed children

    University of Cincinnati (UC) environmental health researchers say a therapy commonly used to remove dangerously high levels of lead from the body may also improve muscle functions associated with postural balance and movement in lead-exposed children.

    5 ways White House can use its muscle to undercut Obamacare

    President Donald Trump has vowed to "let Obamacare fail," after legislative efforts to undo the Affordable Care Act have stalled.

    New drug treats inflammation related to inherited heart disease in young athletes

    When young athletes experiences sudden cardiac death as they run down the playing field, it's usually due to arrhythmogenic cardiomyopathy, an inherited heart disease.

    CytRx provides overview of clinical development programs, reports 2014 Q3 financial results

    CytRx Corporation (CYTR), a biopharmaceutical research and development company specializing in oncology, today reported financial results for the three months ended September 30, 2014, and also provided an overview of recent accomplishments by and upcoming milestones for its clinical development programs.

    Read more Medical News

    › Verified 3 days ago

Mineral and Bone Disorder

An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at BAY Area Dialysis Corpus Christi with elevated calcium levels.

Patients with hypercalcemia131
Hypercalcemia patient months1254
Hypercalcemia patients with serumcalcium greater than 10.2 mg
Patients with Serumphosphor137
Patients with Serumphosphor less than 3.5 mg/dL
Patients with Serumphosphor from 3.5 to 4.5 mg/dL
Patients with Serumphosphor from 4.6 to 5.5 mg/dL
Patients with Serumphosphor from 5.6 to 7 mg/dL
Patients with Serumphosphor greater than 7 mg/dL

News Archive

Federal nutrition program improves health of pregnant women and children

A major 2009 revision to a federal nutrition program for low-income pregnant women and children improved recipients' health on several key measures, researchers at UC San Francisco have found.

Succimer therapy improves balance and movement in lead-exposed children

University of Cincinnati (UC) environmental health researchers say a therapy commonly used to remove dangerously high levels of lead from the body may also improve muscle functions associated with postural balance and movement in lead-exposed children.

5 ways White House can use its muscle to undercut Obamacare

President Donald Trump has vowed to "let Obamacare fail," after legislative efforts to undo the Affordable Care Act have stalled.

New drug treats inflammation related to inherited heart disease in young athletes

When young athletes experiences sudden cardiac death as they run down the playing field, it's usually due to arrhythmogenic cardiomyopathy, an inherited heart disease.

CytRx provides overview of clinical development programs, reports 2014 Q3 financial results

CytRx Corporation (CYTR), a biopharmaceutical research and development company specializing in oncology, today reported financial results for the three months ended September 30, 2014, and also provided an overview of recent accomplishments by and upcoming milestones for its clinical development programs.

Read more Medical News

› Verified 3 days ago

Vascular Access

The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.

Patients included in arterial venous fistula and catheter summaries 101
Patient months included in arterial venous fistula and catheter summaries 733
Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment
Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer

News Archive

Federal nutrition program improves health of pregnant women and children

A major 2009 revision to a federal nutrition program for low-income pregnant women and children improved recipients' health on several key measures, researchers at UC San Francisco have found.

Succimer therapy improves balance and movement in lead-exposed children

University of Cincinnati (UC) environmental health researchers say a therapy commonly used to remove dangerously high levels of lead from the body may also improve muscle functions associated with postural balance and movement in lead-exposed children.

5 ways White House can use its muscle to undercut Obamacare

President Donald Trump has vowed to "let Obamacare fail," after legislative efforts to undo the Affordable Care Act have stalled.

New drug treats inflammation related to inherited heart disease in young athletes

When young athletes experiences sudden cardiac death as they run down the playing field, it's usually due to arrhythmogenic cardiomyopathy, an inherited heart disease.

CytRx provides overview of clinical development programs, reports 2014 Q3 financial results

CytRx Corporation (CYTR), a biopharmaceutical research and development company specializing in oncology, today reported financial results for the three months ended September 30, 2014, and also provided an overview of recent accomplishments by and upcoming milestones for its clinical development programs.

Read more Medical News

› Verified 3 days ago

Hospitalization Rate

The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.

Standard Hospitalization Summary Ratio(SHR) YearJanuary, 2016 - December, 2016
Patients in facility's Hospitalization Summary
Hospitalization Rate in facility (Not Available)
Hospitalization Rate: Upper Confidence Limit
Hospitalization Rate: Lower Confidence Limit

News Archive

Federal nutrition program improves health of pregnant women and children

A major 2009 revision to a federal nutrition program for low-income pregnant women and children improved recipients' health on several key measures, researchers at UC San Francisco have found.

Succimer therapy improves balance and movement in lead-exposed children

University of Cincinnati (UC) environmental health researchers say a therapy commonly used to remove dangerously high levels of lead from the body may also improve muscle functions associated with postural balance and movement in lead-exposed children.

5 ways White House can use its muscle to undercut Obamacare

President Donald Trump has vowed to "let Obamacare fail," after legislative efforts to undo the Affordable Care Act have stalled.

New drug treats inflammation related to inherited heart disease in young athletes

When young athletes experiences sudden cardiac death as they run down the playing field, it's usually due to arrhythmogenic cardiomyopathy, an inherited heart disease.

CytRx provides overview of clinical development programs, reports 2014 Q3 financial results

CytRx Corporation (CYTR), a biopharmaceutical research and development company specializing in oncology, today reported financial results for the three months ended September 30, 2014, and also provided an overview of recent accomplishments by and upcoming milestones for its clinical development programs.

Read more Medical News

› Verified 3 days ago